Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients-Reference-Cited by-同舟云学术

Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients

Published:2016-12 Issue:12 Volume:11 Page:2227-2237
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Samson Pamela,Robinson Clifford,Bradley Jeffrey,Lockhart A. Craig,Puri Varun,Broderick Stephen,Kreisel Daniel,Krupnick A. Sasha,Patterson G. Alexander,Meyers Bryan,Crabtree Traves

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma;Murphy;J Gastrointest Surg,2013

2. Outcomes in the management of esophageal cancer;Paul;J Surg Oncol,2014

3. Patterns of recurrence after trimodality therapy for esophageal cancer;Dorth;Cancer,2014

4. Preoperative chemotherapy for resectable thoracic esophageal cancer;Kidane;Cochrane Database Syst Rev,2015

5. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of immunochemotherapy followed by surgery or chemoradiotherapy in locally advanced esophageal squamous cell cancer;International Immunopharmacology;2024-11

2. Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study;Annals of Surgical Oncology;2024-08-23

3. Complete pathologic response in esophageal adenocarcinoma: does it make a difference?;Diseases of the Esophagus;2024-08-22

4. Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma;Molecular Cancer;2024-05-10

5. Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer;Cancer Research Communications;2024-01-25